K.J. Harrison & Partners’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,000
Closed -$50K 250
2022
Q2
$50K Buy
+10,000
New +$52.4K 0.01% 185

Other funds holding CELL

K.J. Harrison & Partners's CELL Position: Q3 2022 in Review

K.J. Harrison & Partners sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2022, closing a stake of 10,000 shares — an estimated $50K sold.

K.J. Harrison & Partners first reported a position in CELL in Q2 2022 and held it in 1 quarter. The position peaked at $50K in Q2 2022. 113 funds tracked by Wall St. Rank hold CELL as of Q3 2022.

  • K.J. Harrison & Partners reported no remaining PhenomeX Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • K.J. Harrison & Partners sold 10,000 PhenomeX Inc. Common Stock shares in Q3 2022, an estimated $50K.
  • K.J. Harrison & Partners first reported a position in PhenomeX Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • K.J. Harrison & Partners's PhenomeX Inc. Common Stock position peaked at $50K in Q2 2022.
  • 113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2022.

Based on K.J. Harrison & Partners's 13F filing for Q3 2022, filed 21 Oct 2022.